Clinical Trials in Georgia

Browse 98 Georgia Medical Studies Across 999 Cities

45 Phase 3 Trial · 4395 Georgia Clinics

Clinical TrialsClinical Trials in Georgia
Reviewed by Michael Gill, B. Sc.
10 Georgia Clinical Trials Near Me
Top Cities for Georgia Clinical Trials
Image of Atlanta in Georgia.
Atlanta
91Active Trials
Emory UniversityTop Active Site
Image of Miami in Florida.
Miami
87Active Trials
University of Miami Miller School of Medicine-Sylvester Cancer CenterTop Active Site
Georgia Clinical Trials by Phase of Trial
N/A Georgia Clinical Trials
11Active Georgia Clinical Trials
11Number of Unique Treatments
348Number of Active Locations
Impella CP® / Impella CP® with SmartAssist® / Impella 2.5®SAPIEN M3 valve and dockParticipants with history of ASCVDnVNSRobotic NSM with da Vinci SPEmotional working memory trainingSPIRITExcision of the A1 pulley
Most Recent Georgia Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
Seladelpar 10 mg for Primary Biliary Cirrhosis
9/5/2023
Phase 3
Open Label for Attention Deficit Hyperactivity Disorder (ADHD)
5/24/2023
Phase 4
Double-Blind Treatment Period: Low Dose Atogepant (12-17 yrs) for Migraine
5/1/2023
Phase 3
ABBV-552 Dose A for Alzheimer's Disease
4/27/2023
Phase 2
Ligelizumab 120 mg for Food Allergy
4/27/2023
Phase 3

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 24th, 2021

Last Reviewed: September 14th, 2023

References1 Ginsburg AS, Srikantiah P. Respiratory syncytial virus: promising progress against a leading cause of pneumonia. Lancet Glob Health. 2021 Dec;9(12):e1644-e1645. doi: 10.1016/S2214-109X(21)00455-1. Epub 2021 Nov 11. No abstract available. https://pubmed.ncbi.nlm.nih.gov/347741842 Ginsburg AS, Srikantiah P. Respiratory syncytial virus: promising progress against a leading cause of pneumonia. Lancet Glob Health. 2021 Dec;9(12):e1644-e1645. doi: 10.1016/S2214-109X(21)00455-1. Epub 2021 Nov 11. https://pubmed.ncbi.nlm.nih.gov/347741843 Feagan BG, Schreiber S, Afzali A, Rieder F, Hyams J, Kollengode K, Pearlman J, Son V, Marta C, Wolf DC, D'Haens GG. Ozanimod as a novel oral small molecule therapy for the treatment of Crohn's disease: The YELLOWSTONE clinical trial program. Contemp Clin Trials. 2022 Nov;122:106958. doi: 10.1016/j.cct.2022.106958. Epub 2022 Oct 5. https://pubmed.ncbi.nlm.nih.gov/362087204 Feagan BG, Schreiber S, Afzali A, Rieder F, Hyams J, Kollengode K, Pearlman J, Son V, Marta C, Wolf DC, D'Haens GG. Ozanimod as a novel oral small molecule therapy for the treatment of Crohn's disease: The YELLOWSTONE clinical trial program. Contemp Clin Trials. 2022 Oct 5;122:106958. doi: 10.1016/j.cct.2022.106958. [Epub ahead of print] https://pubmed.ncbi.nlm.nih.gov/362087205 Feagan BG, Schreiber S, Afzali A, Rieder F, Hyams J, Kollengode K, Pearlman J, Son V, Marta C, Wolf DC, D'Haens GG. Ozanimod as a novel oral small molecule therapy for the treatment of Crohn's disease: The YELLOWSTONE clinical trial program. Contemp Clin Trials. 2022 Oct 5:106958. doi: 10.1016/j.cct.2022.106958. [Epub ahead of print] https://pubmed.ncbi.nlm.nih.gov/362087206 Feil K, Matusevicius M, Herzberg M, Tiedt S, Kupper C, Wischmann J, Schonecker S, Mengel A, Sartor-Pfeiffer J, Berger K, Dimitriadis K, Liebig T, Dieterich M, Mazya M, Ahmed N, Kellert L. Minor stroke in large vessel occlusion: A matched analysis of patients from the German Stroke Registry-Endovascular Treatment (GSR-ET) and patients from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register (SITS-ISTR). Eur J Neurol. 2022 Jun;29(6):1619-1629. doi: 10.1111/ene.15272. Epub 2022 Feb 19. https://pubmed.ncbi.nlm.nih.gov/351223717 Lusebrink E, Kellnar A, Krieg K, Binzenhofer L, Scherer C, Zimmer S, Schrage B, Fichtner S, Petzold T, Braun D, Peterss S, Brunner S, Hagl C, Westermann D, Hausleiter J, Massberg S, Thiele H, Schafer A, Orban M. Percutaneous Transvalvular Microaxial Flow Pump Support in Cardiology. Circulation. 2022 Apr 19;145(16):1254-1284. doi: 10.1161/CIRCULATIONAHA.121.058229. Epub 2022 Apr 18. https://pubmed.ncbi.nlm.nih.gov/354361358 Chen CT, Lin JW, Wu CH, Kuo RN, Shih CH, Hou PC, Yen DH, How CK. A Simple Risk Score for Predicting Neurologic Outcome in Out-of-Hospital Cardiac Arrest Patients After Targeted Temperature Management. Crit Care Med. 2022 Mar 1;50(3):428-439. doi: 10.1097/CCM.0000000000005266. https://pubmed.ncbi.nlm.nih.gov/344958809 Song MK, Unruh ML, Manatunga A, Plantinga LC, Lea J, Jhamb M, Kshirsagar AV, Ward SE. SPIRIT trial: A phase III pragmatic trial of an advance care planning intervention in ESRD. Contemp Clin Trials. 2018 Jan;64:188-194. doi: 10.1016/j.cct.2017.10.005. Epub 2017 Oct 6. https://pubmed.ncbi.nlm.nih.gov/2899328610 Brastianos PK, Twohy EL, Gerstner ER, Kaufmann TJ, Iafrate AJ, Lennerz J, Jeyapalan S, Piccioni DE, Monga V, Fadul CE, Schiff D, Taylor JW, Chowdhary SA, Bettegowda C, Ansstas G, De La Fuente M, Anderson MD, Shonka N, Damek D, Carrillo J, Kunschner-Ronan LJ, Chaudhary R, Jaeckle KA, Senecal FM, Kaley T, Morrison T, Thomas AA, Welch MR, Iwamoto F, Cachia D, Cohen AL, Vora S, Knopp M, Dunn IF, Kumthekar P, Sarkaria J, Geyer S, Carrero XW, Martinez-Lage M, Cahill DP, Brown PD, Giannini C, Santagata S, Barker FG 2nd, Galanis E. Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations. J Clin Oncol. 2023 Jan 20;41(3):618-628. doi: 10.1200/JCO.21.02371. Epub 2022 Oct 26. https://pubmed.ncbi.nlm.nih.gov/36288512
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top